Pricing
  1. JP-listed companies
  2. PhoenixBio Co.,Ltd.
  3. Financials
  4. Pretax margin (%)

PhoenixBio Co.,Ltd.【JP:6190】

Market cap
¥1.8B
P/E ratio
16.8x
Phoenix Bio provides pharmaceutical testing services using PXB mice with human liver cells to help drug companies predict how medicines work in people.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 2025-10.1-496.76%
Mar 31, 20242.5-89.46%
Mar 31, 202324.1-349.22%
Mar 31, 2022-9.7-56.27%
Mar 31, 2021-22.1+131.00%
Mar 31, 2020-9.6-58.00%
Mar 31, 2019-22.8-23.11%
Mar 31, 2018-29.6-373.01%
Mar 31, 201710.8-11.51%
Mar 31, 201612.3+72.36%
Mar 31, 20157.1+60.97%
Mar 31, 20144.4-172.58%
Mar 31, 2013-6.1-79.62%
Mar 31, 2012-29.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)